ArticleCancer immunology research2016

Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.

Amanda J Vandeveer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.